Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00220727 · ClinicalTrials.gov registry record · Phase 2
Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP
A Phase 2 study, sponsored by Grifols Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT00220727: Completed Phase 2 study, sponsored by Grifols Therapeutics.
NCT00220727 is a Phase 2 study that has completed, run by Grifols Therapeutics. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00220727, a Phase 2 study, has completed, sponsored by Grifols Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
The objective of this study is to determine if the safety and tolerability of Immune Globulin Intravenous (Human), 10% Caprylate/Chromatograph Purified (IGIV-C) is similar when infused at two different infusion rates.
Primary Outcome
Free hemoglobin as a measure to assess hemolysis.
Interventions
- DRUG Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2003-07 |
| Est. Completion | 2003-10 |
| Phase | Phase 2 |
What the finished NCT00220727 record still lists
NCT00220727 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified is the first listed.
NCT00220727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00220727 about?
NCT00220727 is a clinical study titled "Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP". The objective of this study is to determine if the safety and tolerability of Immune Globulin Intravenous (Human), 10% Caprylate/Chromatograph Purified (IGIV-C) is similar when infused at two different infusion rates.
What is the current status of trial NCT00220727?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2003-07. Estimated completion is 2003-10.
What interventions are being tested in trial NCT00220727?
The interventions under investigation include: Immune Globulin IV [Human], 10% Caprylate/Chromatography Purified (DRUG).
Who is sponsoring clinical trial NCT00220727?
This trial is sponsored by Grifols Therapeutics, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00220727's enrollment target sits among peer trials
8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia